Building upon and complementing TWAS, CWAS utilizes specific cistrome data – like the androgen receptor (AR) and H3K27 acetylation (H3K27ac) in prostate cancer – to assess the impact of SNP alleles on peak intensity, employing methods like LASSO penalized regression or single SNP models. This evidence concerns the gene AR and prostate cancer.